Filed: 4/27/2023ACC: 0001104659-23-051214
📋 What this filing means
RIVERVEST VENTURE MANAGEMENT LLC filed this quarterly 13F‑HR report disclosing 6 equity positions with a total reported market value of $86.43M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
6
Positions
$86.43M
Total AUM (reported)
13.72M
Total Shares
Allocation by class
COMMON$86.43M100.0%
Portfolio Concentration
Top 3$75.10M86.9%
4–10$11.34M13.1%
Top 3 weight
86.9%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 13.72M
Sole
Full voting authority
11.76M
shares
% of voting shares85.7%
Shared
Joint voting authority
1.96M
shares
% of voting shares14.3%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole4
Shared0
Other2
Dominant voting typeSole · 85.7% of voting shares
Institutional Holdings6
Rows:
Mirum Pharmaceuticals, Inc.
SOLEShares1.62M
TypeSH
Market value$38.94M
45.05%
Sole
1.62M
Shared
0.00
None
0.00
Allakos, Inc.
OTRShares4.89M
TypeSH
Market value$21.75M
25.17%
Sole
3.35M
Shared
1.54M
None
0.00
Reneo Pharmaceuticals, Inc.
SOLEShares2.41M
TypeSH
Market value$14.41M
16.67%
Sole
2.41M
Shared
0.00
None
0.00
Spruce Bioscience, Inc.
SOLEShares2.94M
TypeSH
Market value$6.49M
7.51%
Sole
2.94M
Shared
0.00
None
0.00
Xilio Therapeutics, Inc.
SOLEShares1.44M
TypeSH
Market value$4.57M
5.29%
Sole
1.44M
Shared
0.00
None
0.00
Vapotherm, Inc.
OTRShares423.06K
TypeSH
Market value$278.4K
0.32%
Sole
0.00
Shared
423.06K
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Mirum Pharmaceuticals, Inc.SOLE | Common | 1.62M | SH | $38.94M 45.05% | 1.62M | 0.00 | 0.00 |
Allakos, Inc.OTR | Common | 4.89M | SH | $21.75M 25.17% | 3.35M | 1.54M | 0.00 |
Reneo Pharmaceuticals, Inc.SOLE | Common | 2.41M | SH | $14.41M 16.67% | 2.41M | 0.00 | 0.00 |
Spruce Bioscience, Inc.SOLE | Common | 2.94M | SH | $6.49M 7.51% | 2.94M | 0.00 | 0.00 |
Xilio Therapeutics, Inc.SOLE | Common | 1.44M | SH | $4.57M 5.29% | 1.44M | 0.00 | 0.00 |
Vapotherm, Inc.OTR | Common | 423.06K | SH | $278.4K 0.32% | 0.00 | 423.06K | 0.00 |